ArticleCancer gene therapy2006
Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer.
K Naruishi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it